Identifiers for both drugs and medical devices in the U.S. are going through some transition. The Unique Device Identification System final rule (UDI Rule) requires device labelers to include the UDI on device labels and packages, except where the rule provides for an exception or alternative. Drug are assigned a unique identifier called the National Drug Code (NDC). All drugs in U.S. commercial distribution are required to be listed with the Food and Drug Administration (FDA) using the NDC. In this session, the latest update on the transition for each identifier is discussed, and all the compliance dates and requirements surrounding the transition will be provided.

Format of the National Drug Code in the United States

For it's 35th anniversary, DIA Europe is back in Basel, where all thought leaders meet in person to discuss, inspire, and network.

Join us in Basel: March 22-24, 2023

DIA Europe 2023 is designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need for your everyday job. Your participation will accelerate your growth and your organization's performance in the drug development ecosystem.

Gathering innovative thought leaders from the entire life science landscape, DIA always has the aspiration to be ahead of current developments, reflected by 4 new content tracks in 2023:

- Artificial Intelligence and Data Science
- EU Health Policy and Regulatory Strategy
- Medical Devices and Combination Products
- Professional Development

DIA Europe 2023

A global, member-driven non-profit organization mobilizing life sciences and healthcare. DIA fosters innovation to improve health and well-being worldwide. Professionals from 80 countries continue to engage with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.